Brief: Glaxosmithkline Pharmaceuticals Ltd Receives Final Order With Tax Demand Liability Of 232.1 Mln Rupees For AY 2023-24
24/03/2026 07:34
March 24 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd GLAX.NS: GLAXOSMITHKLINE PHARMACEUTICALS LTD - RECEIVES FINAL ORDER WITH TAX DEMAND LIABILITY OF 232.1 MILLION RUPEES FOR AY 2023-2024 Source text: ID:nBSE7RqnSk Further company coverage: GLAX.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsIndia's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees
India's Cipla jumps on FDA approval for Ventolin HFA generic inhaler
Brief: Glaxosmithkline Pharmaceuticals Receives TDS Demand Liability Of 20.1 Million Rupees
Brief: Glaxosmithkline Pharmaceuticals Ltd Receives Final Order With Tax Demand Liability Of 232.1 Mln Rupees For AY 2023-24